These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30281234)

  • 1. Reducing Barriers to 17-Hydroxprogestrone Caproate (17P) Injections to Prevent Recurrent Preterm Birth in Mississippi.
    Bofill JA; Collier CH; Pearson M; Shwayder JM; Morrison JC
    J Miss State Med Assoc; 2016 Nov; 57(11):350-351. PubMed ID: 30281234
    [No Abstract]   [Full Text] [Related]  

  • 2. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length.
    Romero J; Rebarber A; Saltzman DH; Schwartz R; Peress D; Fox NS
    Am J Obstet Gynecol; 2012 Jul; 207(1):51.e1-5. PubMed ID: 22595378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy.
    Coleman S; Wallace L; Alexander J; Istwan N
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1034-8. PubMed ID: 21854134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence?
    Barton JR; Barton LA; Istwan NB; Rhea DJ; Desch CN; Sibai BM
    Am J Obstet Gynecol; 2011 Sep; 205(3):269.e1-6. PubMed ID: 22071060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
    Sibai BM; Istwan NB; Palmer B; Stanziano GJ
    Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
    Mackeen AD; Rafael TJ; Zavodnick J; Berghella V
    Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery.
    Gonzalez-Quintero VH; Cordova YC; Istwan NB; Tudela F; Rhea DJ; Romary LM; Marimon A; Desch CN; Stanziano GJ
    Am J Obstet Gynecol; 2011 Sep; 205(3):275.e1-5. PubMed ID: 22071063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes of managed Medicaid members prescribed home administration of 17 α-hydroxyprogesterone caproate.
    Lucas B; Poole-Yaeger A; Istwan N; Stanziano G; Rhea D; Mason M
    Am J Perinatol; 2012 Aug; 29(7):489-96. PubMed ID: 22399213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
    Feghali M; Venkataramanan R; Caritis S
    Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.
    Senat MV; Porcher R; Winer N; Vayssière C; Deruelle P; Capelle M; Bretelle F; Perrotin F; Laurent Y; Connan L; Langer B; Mantel A; Azimi S; Rozenberg P;
    Am J Obstet Gynecol; 2013 Mar; 208(3):194.e1-8. PubMed ID: 23433324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth.
    Society for Maternal-Fetal Medicine (SMFM) Publications Committee
    Am J Obstet Gynecol; 2017 Mar; 216(3):B11-B13. PubMed ID: 28126367
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17-alpha-hydroprogesterone caproate and cervical changes.
    Facchinetti F
    Am J Obstet Gynecol; 2010 Sep; 203(3):e9; author reply e10. PubMed ID: 20537309
    [No Abstract]   [Full Text] [Related]  

  • 17. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH; Istwan NB; Rhea DJ; Smarkusky L; Hoffman MC; Stanziano GJ
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.
    Nelson DB; Herrera CL; McIntire DD; Cunningham FG
    Am J Obstet Gynecol; 2024 Jan; 230(1):1-9. PubMed ID: 37798189
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.
    Petrini JR; Callaghan WM; Klebanoff M; Green NS; Lackritz EM; Howse JL; Schwarz RH; Damus K
    Obstet Gynecol; 2005 Feb; 105(2):267-72. PubMed ID: 15684150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.